Neuropathological (N) |
|
Other (O) |
polyQ protein aggregates |
549 |
Lifespan |
69 |
Hormonal dysregulation |
13 |
Neuronal morphology alterations |
145 |
Organ pathology |
54 |
SHIRPA change |
6 |
Neuronal physiology alterations |
138 |
Body weight change |
54 |
Body temperature alteration |
4 |
Brain morphology alteration |
88 |
polyQ protein aggregates |
51 |
Circadian rhythm alteration |
3 |
Neuronal loss |
62 |
Muscle abnormalities |
42 |
Abnormal urination |
2 |
Glial abnormalities |
55 |
Posture abnormalities |
32 |
Hearing impairment |
2 |
Retinopathy |
16 |
Fertility |
19 |
Diabetes insipidus |
1 |
Abnormal myelination |
10 |
Adipose tissue dysfunction |
15 |
Narcolepsy |
1 |
Sensorimotor gating impairment |
10 |
Metabolism alteration |
14 |
Visual impairment |
1 |
Neurogenesis impairment |
8 |
Diabetes mellitus |
13 |
|
|
Autonomous nervous system (ANS) dysfunction |
1 |
|
|
|
|
Cognitive (C) |
Motor (M) |
Learning and memory impairment |
42 |
Balance and coordination alterations |
111 |
Tremor |
25 |
Affective function alteration |
23 |
Locomotor impairment |
97 |
Abnormal sensorimotor response |
21 |
|
|
Gait alteration |
52 |
Seizures |
11 |
|
|
Clasping behavior |
37 |
Dyskinesia |
7 |
|
|
Muscle strength impairment |
29 |
|
|